Maryland considers ban on bath salts designer drug: Part 2

Maryland considers ban on bath salts designer drug: Part 2

As reported in the previous post, the use of the designer drug, bath salts, has been increasing around the country, as have reports of people experiencing bad health reactions from taking the drug and sometimes hurting themselves or others.

The designer drug contains mephedrone and MDPV and neither is banned currently under federal law. The federal Analog Act says drugs that mimic illegal drugs are also illegal and have pursued charges against some sellers, but they need to prove that the drugs were being sold for human consumption even though labels on the drug say “not for human consumption.”

People have been known to experience psychotic breaks from reality when taking different kinds of drugs, but many public health officials and doctors have described this drug as one of the more dangerous to immediate and long-term health and safety that they have seen. The designer drug has been declared illegal in 28 states, and Maryland is looking to join that group. Public health officials in Maryland want mephedrone and MDPV on the list of Schedule 1 Controlled Dangerous Substances in the state.

Public health officials say that the drug is not widely available in the state. According to an article in The Baltimore Sun, 31 people have reported poisoning by bath salts to poison control centers in the state and at least one person has died from using the bath salts. The ban on the sale and distribution of the drugs could start by September 1 if it is approved.

Sources:

The New York Times, “An Alarming New Stimulant, Legal in Many States,” Abby Goodnough and Katie Zezima, 16 July 2011

Contact Law Offices of James E. Crawford, Jr. and Associates!

All Consultations are Free and Confidential
    • Please enter your name.
    • This isn't a valid phone number.
    • Please enter your email address.
      This isn't a valid email address.
    • Please make a selection.
    • Please make a selection.
    • Please enter a message.